Hidenori Wake
- Clinical Biochemistry top 0.2%
- Molecular Biology top 10%
- Neurology top 1%
- Immunology top 5%
- Epidemiology top 10%
- Co-authors
- Masahiro NishiboriShuji MoriKeyue LiuHideo TakahashiTadashi YoshinoKiyoshi TeshigawaraDengli WangIsao Date
- Topics
- Advanced Glycation End Products research (56 papers)Immune Response and Inflammation (17 papers)Neuroinflammation and Neurodegeneration Mechanisms (14 papers)
- Partner nations
- JapanChinaUnited States
In The Last Decade
Hidenori Wake
86 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 110
- Clinical Biochemistry 1.1k
- Molecular Biology 774
- Neurology 695
- Immunology 623
- Epidemiology 347
Countries citing papers authored by Hidenori Wake
This map shows the geographic impact of Hidenori Wake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidenori Wake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidenori Wake more than expected).
Fields of papers citing papers by Hidenori Wake
This network shows the impact of papers produced by Hidenori Wake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidenori Wake. The network helps show where Hidenori Wake may publish in the future.
Co-authorship network of co-authors of Hidenori Wake
This figure shows the co-authorship network connecting the top 25 collaborators of Hidenori Wake. A scholar is included among the top collaborators of Hidenori Wake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidenori Wake. Hidenori Wake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 6 | |
| 4 | 4 | |
| 5 | 3 | |
| 6 | 10 | |
| 7 | 0 | |
| 8 | 19 | |
| 9 | 16 | |
| 10 | 9 | |
| 11 | 17 | |
| 12 | 10 | |
| 13 | 30 | |
| 14 | 38 | |
| 15 | 39 | |
| 16 | 18 | |
| 17 | 75 | |
| 18 | 43 | |
| 19 | 7 | |
| 20 | 10 |
About Hidenori Wake
Hidenori Wake is a scholar working on Clinical Biochemistry, Neurology and Immunology, having authored 90 papers that have together received 2.7k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (56 papers), Immune Response and Inflammation (17 papers) and Neuroinflammation and Neurodegeneration Mechanisms (14 papers). The work is most often cited by research in Clinical Biochemistry (1.1k citations), Neurology (695 citations) and Immunology (623 citations). Hidenori Wake has collaborated with scholars based in Japan, China and United States. Frequent co-authors include Masahiro Nishibori, Shuji Mori, Keyue Liu, Hideo Takahashi, Tadashi Yoshino, Kiyoshi Teshigawara, Dengli Wang, Isao Date, Jiyong Zhang and Aiji Ohtsuka. Their work appears in journals such as The Journal of Immunology, PLoS ONE and Stroke.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.